Phathom Pharmaceuticals, Inc.
PHAT
$11.02
$0.646.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M |
| Total Depreciation and Amortization | 172.00K | 177.00K | 193.00K | 191.00K | 197.00K |
| Total Amortization of Deferred Charges | 734.00K | 696.00K | 629.00K | 589.00K | 500.00K |
| Total Other Non-Cash Items | 18.13M | 17.43M | 19.21M | 19.84M | 20.65M |
| Change in Net Operating Assets | -5.95M | -8.91M | -9.04M | 1.39M | -626.00K |
| Cash from Operations | -62.73M | -84.93M | -63.46M | -63.57M | -70.72M |
| Capital Expenditure | -97.00K | -18.00K | -5.00K | -44.00K | -46.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -97.00K | -18.00K | -5.00K | -44.00K | -46.00K |
| Total Debt Issued | -- | -- | 24.75M | 0.00 | 24.75M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.00K | -- | 1.30M | 122.06M | 21.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.00K | -- | 26.05M | 122.06M | 24.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.75M | -84.95M | -37.42M | 58.44M | -46.00M |